Skip to main content

Table 4 Propensity score match-controlled (1:1) cohort by age, prostate volume and comorbidity

From: Analysis of risk factors of bladder neck contracture following transurethral surgery of prostate

 

All patients

Cohort

Resection group (N = 135)

Enucleation group (N = 51)

P value

Resection group (N = 49)

Enucleation group (N = 49)

P value

Age (years)

68.8 ± 10.3

72.9 ± 7.4

0.049*

71.6 ± 8.1

72.5 ± 7.2

0.44

Prostate volume (ml)

51.02 ± 20.72

56.37 ± 19.90

0.72

57.40 ± 23.59

54.90 ± 18.87

0.42

PSA (ng/ml)

8.77 ± 15.22

8.47 ± 13.51

0.57

8.08 ± 7.90

7.88 ± 13.4

0.88

Maximal urinary flow (ml/sec)

9.44 ± 7.33

8.47 ± 13.51

0.58

8.46 ± 5.83

8.10 ± 6.41

0.79

Post-voiding residual urine (ml)

129.28 ± 171.40

119.94 ± 167.55

0.45

124.20 ± 156.88

119.88 ± 170.97

0.20

Foley insertion before TURP or ThuP (yes/no)

26/109

10/41

0.96

9/40

9/40

1.0

Pre-operation hemoglobin (ng/ml)

14.06 ± 1.43

13.99 ± 1.11

0.12

14.06 ± 1.60

14.02 ± 1.11

0.49

Post-operation Hemoglobin (ng/ml)

13.41 ± 1.47

13.29 ± 1.08

0.01*

13.28 ± 1.68

13.31 ± 1.07

0.86

Hemoglobin change (ng/ml)

0.66 ± 0.64

0.68 ± 0.71

0.82

0.77 ± 0.74

0.69 ± 0.72

0.13

Prostate resection weight (g)

14.64 ± 11.69

16.10 ± 15.10

0.045*

17.81 ± 13.65

15.33 ± 14.33

0.14

Percentage of prostate resected (%)

27.77 ± 14.93

26.65 ± 20.57

0.015*

30.10 ± 14.75

26.21 ± 20.45

0.71

Surgical time (min)

95.71 ± 32.76

111.69 ± 35.43

0.49

102.67 ± 29.92

110.33 ± 35.47

0.75

Hospital stay (days)

3.13 ± 0.50

3.14 ± 0.49

0.31

3.06 ± 0.48

3.14 ± 0.50

0.80

Smoking (yes/no)

48/87

10/41

0.036*

15/34

10/39

0.33

Hypertension (yes/no)

65/70

26/25

0.73

25/24

24/25

1.0

Diabetes mellitus (yes/no)

25/110

7/44

0.44

9/40

7/42

0.79

Cerebrovascular accidents (yes/no)

12/123

6/45

0.55

5/44

5/44

1.0

Coronary artery disease (yes/no)

22/113

9/42

0.83

10/39

8/41

0.82

Chronic kidney disease (yes/no)

16/119

9/42

0.30

8/41

8/41

1.0

Number of comorbidities (≥ 2/ ≤ 1)

38/97

18/33

0.34

15/34

16/33

1.0

Prostate cancer (yes/no)

15/120

3/48

0.28

5/44

3/46

0.73

Other malignancy (yes/no)

9/126

1/50

0.20

3/46

1/48

0.63

Concurrent ESCL (yes/no)

9/126

1/50

0.20

3/46

1/48

0.63

Recatherization after surgery (yes/no)

4/131

5/46

0.052

1/48

5/44

0.22

Postopertive urinary tract infection (yes/no)

3/132

1/50

0.91

1/48

1/48

1

BNC (yes/no)

45/90

17/34

1

13/36

16/33

0.69

  1. * means  p < 0.05